Skip to content
The Nexus
DossierENTITY

Sickle-cell anemia

Coverage of Sickle-cell anemia in the Nexus archive.

Earliest in view: Apr 9 · 20:28 UTCMost recent: Apr 9 · 20:28 UTC
Co-mentioned in this coverage
CRISPR/Cas9technology1β-Thalassaemiatopic1FDAorganization1Chinese Collaborationorganization1
Recent coverage
  • HEALTHApr 9 · 20:28 UTCARS TECHNICA
    Clinical trial shows gene editing works for β-Thalassaemia, too

    A clinical trial demonstrates that gene editing using an improved CRISPR/Cas9 system successfully treats β-Thalassaemia, a disease related to sickle-cell anemia. The therapy builds on the FDA-approved CRISPR-based treatment for sickle-cell anemia, developed through a large Chinese collaboration.

Sickle-cell anemia · Dossier · The Nexus